“CPPA is pleased to partner with ASHP in this valuable pharmacy practice accreditation venture,” stated Lynnae M. Mahaney, BSPharm, MBA, FASHP, CPPA Executive Director. “ASHP’s leadership and experience in hospital and health-system pharmacy practice will be important as we prepare to develop accreditation standards for additional practice settings. “By joining with CPPA, ASHP continues to demonstrate its longstanding support for voluntary accreditation processes that improve patient care quality.”
“ASHP is pleased to be joining with CPPA on this important effort to help health care organizations demonstrate quality and excellence in the medication use process,” said ASHP CEO Paul W. Abramowitz, PharmD, FASHP. “ASHP joined CPPA because we believe that patient care will be improved through the development and widespread use of voluntary accreditation standards that help ensure quality throughout the entire medication-use process.”
CPPA oversees the development and implementation of the standards process for the pharmacy practice accreditation program. CPPA’s board has approved the first standards for community pharmacy practice accreditation and expects to release the standards and open the accreditation process in early 2013. The voluntary community pharmacy practice accreditation program will be focused on recognizing quality, enhancing patient safety and providing a mechanism for excellence-committed community pharmacy practices to distinguish themselves. CPPA anticipates the future development of accreditation standards for other pharmacy practice settings.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs